To study N-terminal pro-brain natriuretic peptide (NTproBNP) levels in patients with non-alcoholic fatty liver disease (NAFLD) and acute decompensated heart failure (ADHF) and to evaluate its impact on clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Misan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: